ReShape Lifesciences (QB) Stock Price - RSLS

4.90
0.00 (0.0%)
4.90
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
ReShape Lifesciences Inc (QB) RSLS OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 4.90 0.00 0.00 0.00 4.90 09:24:42
Bid Price Ask Price Spread Spread % News
3.62 7.10 3.48 49.01% - -
Stock Trades Traded Volume Average Volume 52 Week Range
1 11 515 0.03 - 14.25
Last Trade Time Type Quantity Stock Price Currency
09:56:53 11 $ 3.67 USD

ReShape Lifesciences (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 26.84M 5.48M 180.07k $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
21.00 $ - 0.00% - -

more financials information »

ReShape Lifesciences (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RSLS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.314.903.254.001,0011.5948.04%
1 Month4.555.103.254.247110.357.69%
3 Months5.505.553.004.63747-0.60-10.91%
6 Months5.3414.253.006.281,867-0.44-8.24%
1 Year0.0714.250.030.1166567105,8644.836,900.0%
3 Years0.24114.250.030.1545753112,1504.661,933.2%
5 Years0.24114.250.030.1545753112,1504.661,933.2%

ReShape Lifesciences (QB) Description

ReShape Lifesciences is a developer of minimally invasive medical devices that advance bariatric surgery to treat obesity and metabolic diseases. Our current portfolio includes the LAP-BAND(R) Adjustable Gastric Banding System and the ReShape Vest(TM), an investigational device, to help treat more patients with obesity. Our vision is to be recognized as a leading medical technology company focused on the design, development and commercialization of transformative technology to treat obesity and metabolic diseases.


Your Recent History
USOTC
RSLS
ReShape Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.